2079-51-8

2079-51-8 structure

2079-51-8 structure

Name: 1-[4-(2-piperidin-1-ylethoxy)phenyl]ethanone
Chemical Name: 1-[4-(2-piperidin-1-ylethoxy)phenyl]ethanone
CAS Number: 2079-51-8
Molecular Formula: C₁₅H₂₁NO₂
Molecular Weight: 247.33300
Create Date: 2016-11-09 14:03:23
Modify Date: 2024-01-09 21:39:03

Name	1-[4-(2-piperidin-1-ylethoxy)phenyl]ethanone
Synonyms	4'-(2-Piperidinoethoxy)acetophenone Ethanone,1-(4-(2-(1-piperidinyl)ethoxy)phenyl) 1-[4-(2-piperidino-ethoxy)-phenyl]-ethanone 1-[4-(2-piperidinoethoxy)phenyl]ethan-1-one ACETOPHENONE,4'-(2-PIPERIDINOETHOXY) 1-[4-(2-Piperidino-aethoxy)-phenyl]-aethanon

Density	1.052g/cm3
Boiling Point	384.6ºC at 760 mmHg
Molecular Formula	C₁₅H₂₁NO₂
Molecular Weight	247.33300
Flash Point	186.4ºC
Exact Mass	247.15700
PSA	29.54000
LogP	2.69180
Vapour Pressure	4.06E-06mmHg at 25°C
Index of Refraction	1.526

CHEMICAL IDENTIFICATION

RTECS NUMBER :: AM9760000

CHEMICAL NAME :: Acetophenone, 4'-(2-piperidinoethoxy)-

CAS REGISTRY NUMBER :: 2079-51-8

BEILSTEIN REFERENCE NO. :: 0170185

LAST UPDATED :: 199612

DATA ITEMS CITED :: 1

MOLECULAR FORMULA :: C15-H21-N-O2

MOLECULAR WEIGHT :: 247.37

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 1500 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: MEXPAG Medicina Experimentalis. (Basel, Switzerland) V.1-11, 1959-64; V.18-19, 1968-69. For publisher information, see JNMDBO. Volume(issue)/page/year: 11,137,1964

HS Code	2933399090

1932-03-2 structure

1932-03-2

99-93-4 structure

99-93-4

~40%

2079-51-8 structure

2079-51-8

Literature: Kumaria, Niharika; Dwivedi, Anil Kumar; Maikhuri, Jagdamba Prasad; Gupta, Gopal; Habib, Saman; Dhar, Janak Dulari; Singh, Satyawan European journal of medicinal chemistry, 2002 , vol. 37, # 11 p. 855 - 864

3040-44-6 structure

3040-44-6

52010-97-6 structure

52010-97-6

~34%

2079-51-8 structure

2079-51-8

Literature: JANSSEN PHARMACEUTICA N.V. Patent: WO2004/7498 A2, 2004 ; Location in patent: Page 20 ; WO 2004/007498 A2

99-93-4 structure

99-93-4

~%

2079-51-8 structure

2079-51-8

Literature: Sharon, Ashoke; Pratap, Ramendra; Vatsyayan, Rit; Maulik, Prakas R.; Roy, Uma; Goel, Atul; Ram, Vishnu Ji Bioorganic and Medicinal Chemistry Letters, 2005 , vol. 15, # 14 p. 3356 - 3360

2008-75-5 structure

2008-75-5

99-93-4 structure

99-93-4

~%

2079-51-8 structure

2079-51-8

Literature: Kumar, Atul; Tripathi, Vishwa Deepak; Kumar, Promod; Gupta, Lalit Prakash; Akanksha; Trivedi, Ritu; Bid, Hemant; Nayak; Siddiqui, Jawed A.; Chakravarti, Bandana; Saxena, Ruchi; Dwivedi, Anila; Siddiquee; Siddiqui; Konwar, Rituraj; Chattopadhyay, Naibedya Bioorganic and Medicinal Chemistry, 2011 , vol. 19, # 18 p. 5409 - 5419

110-89-4 structure

110-89-4

55368-24-6 structure

55368-24-6

~%

2079-51-8 structure

2079-51-8

Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 15, # 14 p. 3356 - 3360

HS Code	2933399090
Summary	2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%